Fiduciary Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Fiduciary Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$556K	Hold	7,399	–	–	0.01%	551
2025 Q4	$585K	Buy	7,399 +1,022	+16%	+$77K	0.01%	520
2025 Q3	$417K	Sell	6,377 -2,174	-25%	-$106K	﹤0.01%	604
2025 Q2	$338K	Buy	8,551 +813	+11%	+$26.6K	﹤0.01%	644
2025 Q1	$233K	Buy	+7,738	New	+$253K	﹤0.01%	739
2020 Q3	–	Sell	-3,637	Closed	-$214K	–	554
2020 Q2	$214K	Buy	+3,637	New	+$202K	0.01%	510
2020 Q1	–	Sell	-3,637	Closed	-$220K	–	515
2019 Q4	$220K	Sell	3,637 -20	-0.5%	-$1.19K	0.01%	490
2019 Q3	$219K	Sell	3,657 -170	-4%	-$11.1K	0.01%	489
2019 Q2	$246K	Sell	3,827 -350	-8%	-$24.7K	0.01%	457
2019 Q1	$339K	Hold	4,177	–	–	0.01%	392
2018 Q4	$226K	Sell	4,177 -106	-2%	-$5.41K	0.01%	415
2018 Q3	$220K	Buy	+4,283	New	+$201K	0.01%	446

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fiduciary Trust's IONS Position: Q1 2026 in Review

Fiduciary Trust held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 7,399 shares worth $556K. The position accounts for 0.01% of the portfolio, ranked #551.

Fiduciary Trust first reported a position in IONS in Q3 2018 and has held it in 12 quarters since. The position peaked at $585K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Fiduciary Trust held 7,399 shares of Ionis Pharmaceuticals worth $556K as of Q1 2026.
Fiduciary Trust left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
Ionis Pharmaceuticals made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #551 holding.
Fiduciary Trust first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 12 quarters since.
Fiduciary Trust's Ionis Pharmaceuticals position peaked at $585K in Q4 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.